Hoepelman AIM - Search Results

1

High efavirenz levels but not neurofilament light plasma levels are associated with poor neurocognitive functioning in asymptomatic HIV patients.

Hakkers CS, Hermans AM, van Maarseveen EM, Teunissen CE, Verberk IMW, Arends JE, Hoepelman AIM. Hakkers CS, et al. Among authors: hoepelman aim. J Neurovirol. 2020 Aug;26(4):572-580. doi: 10.1007/s13365-020-00860-1. Epub 2020 Jun 10. J Neurovirol. 2020. PMID: 32524424 Free PMC article. Clinical Trial.

2

Hepatitis C virus and human immunodeficiency virus coinfection: where do we stand?

Arends JE, Boucher CA, Hoepelman AI. Arends JE, et al. Neth J Med. 2005 May;63(5):156-63. Neth J Med. 2005. PMID: 15952483 Free article. Review.

3

Peginterferon monotherapy for the treatment of acute hepatitis C in HIV-coinfected patients.

Arends JE, Schrover IM, Schaar CG, Mudrikova T, Hoepelman AI. Arends JE, et al. AIDS. 2008 Jul 11;22(11):1381-2. doi: 10.1097/QAD.0b013e3283036cac. AIDS. 2008. PMID: 18580623 No abstract available.

4

Plasma HCV-RNA decline in the first 48 h identifies hepatitis C virus mono-infected but not HCV/HIV-coinfected patients with an undetectable HCV viral load at week 4 of peginterferon-alfa-2a/ribavirin therapy.

Arends JE, Stuart JC, Baak LC, van der Ende ME, van Erpecum KJ, Simons CP, Boland GJ, van Baarle D, Hoepelman AI. Arends JE, et al. J Viral Hepat. 2009 Dec;16(12):867-75. doi: 10.1111/j.1365-2893.2009.01143.x. Epub 2009 May 11. J Viral Hepat. 2009. PMID: 19457139

5

T-cell responses at baseline and during therapy with peginterferon-alpha and ribavirin are not associated with outcome in chronic hepatitis C infected patients.

Arends JE, Claassen MA, van den Berg CH, Nanlohy NM, van Erpecum KJ, Baak BC, Hoepelman AI, Boonstra A, van Baarle D. Arends JE, et al. Antiviral Res. 2010 Sep;87(3):353-60. doi: 10.1016/j.antiviral.2010.06.002. Epub 2010 Jun 12. Antiviral Res. 2010. PMID: 20547185

6

Treatment of acute hepatitis C virus infection in HIV+ patients: Dutch recommendations for management.

Arends JE, Lambers FA, van der Meer JT, Schreij G, Richter C, Brinkman K, Hoepelman AI; The Netherlands Society for AIDS Physicians-NVAB. Arends JE, et al. Neth J Med. 2011 Jan;69(1):43-9. Neth J Med. 2011. PMID: 21325703 Free article.

7

Low doses of the novel caspase-inhibitor GS-9450 leads to lower caspase-3 and -8 expression on peripheral CD4+ and CD8+ T-cells.

Arends JE, Hoepelman AI, Nanlohy NM, Höppener FJ, Hirsch KR, Park JG, van Baarle D. Arends JE, et al. Apoptosis. 2011 Sep;16(9):959-66. doi: 10.1007/s10495-011-0620-2. Apoptosis. 2011. PMID: 21667042 Free PMC article. Clinical Trial.

8

Letter to Mendeni et al.

van der Pas VR, Hoepelman AI, Arends JE. van der Pas VR, et al. Clin Infect Dis. 2011 Sep;53(6):613-4; author reply 614-5. doi: 10.1093/cid/cir479. Clin Infect Dis. 2011. PMID: 21865198 No abstract available.

9

Association between IL28B polymorphisms and first-phase viral load decrease in chronic hepatitis C virus-infected patients treated with peginterferon alfa-2b/ribavirin.

Arends JE, Fransen JH, Hoepelman AI, van Baarle D. Arends JE, et al. Int J Antimicrob Agents. 2011 Dec;38(6):538-9. doi: 10.1016/j.ijantimicag.2011.08.010. Epub 2011 Oct 4. Int J Antimicrob Agents. 2011. PMID: 21974859

10

Pegylated interferon-α monotherapy leads to low response rates in HIV-infected patients with acute hepatitis C.

Arends JE, van Assen S, Stek CJ, Wensing AM, Fransen JH, Schellens IM, Spijkers SN, Mudrikova T, van Baarle D, Sprenger HG, Hoepelman AI. Arends JE, et al. Antivir Ther. 2011;16(7):979-88. doi: 10.3851/IMP1843. Antivir Ther. 2011. PMID: 22024513

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

338 results

Search Page